ArticleOne health (Amsterdam, Netherlands)2025
High serological barriers may contribute to restricted Influenza-A-virus transmission between pigs and humans.
Article in One health (Amsterdam, Netherlands), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- High serological barriers may contribute to restricted Influenza-A-virus transmission between pigs and humans.One health (Amsterdam, Netherlands) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Influenza A viruses (IAV) circulate in both humans and pigs, with bidirectional transmission potentially driving viral evolution. Despite frequent contact and genetic compatibility, observed cross-species transmission remains rare, suggesting the presence of unexplored or little-known barriers. The study investigated transmission dynamics and mechanisms restricting IAV spread at the human-swine interface in Germany. We analyzed 3070 porcine and 333 human nasal swabs from 135 swine farms via RT-qPCR and full-genome sequencing. Concurrently, we conducted serological surveys: 1) Children's sera (urban, no pig contact) for antibodies against circulating swine IAV, and 2) Swine sera for antibodies against human-adapted IAV. Molecular surveillance identified only one zooanthroponosis event and sporadic anthropozoonosis (primarily in children) despite swine IAV strains carrying zoonotic-propensity genetic markers (MxA resistance). Serologically, urban children without pig exposure exhibited marked neutralizing activity against swine IAV, whereas swine sera contained neutralizing antibodies against human IAV strains. Pre-existing cross-reactive immunity-evidenced by unexpected antibody prevalence in both species-creates a more complex interspecies barrier than genetic factors alone. This serological "shield" may critically limit IAV transmission between humans and pigs, reshaping our understanding of zoonotic risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.